Biotech

All Articles

Rivus' phase 2 obesity-related heart failure trial hits endpoint

.Rivus Pharmaceuticals has actually plumped up the potential customers of its own fat-busting, muscl...

Ovid standstills preclinical work, IV system after soticlestat stop working

.Ovid Therapy currently showed last month that it was actually trimming back its headcount as the fi...

Eli Lilly opens $700M nucleic acid R&ampD facility in Boston Port

.Eli Lilly has opened up a $700 thousand R&ampD center in the Boston Port, improving its own RNA as ...

Boundless Biography creates 'moderate' layoffs five months after $100M IPO

.Only five months after safeguarding a $100 million IPO, Limitless Biography is currently giving up ...

Halda's $126M will certainly accelerate 'secure and also eliminate' growth medications

.The preliminary phases of oncology R&ampD aren't short of intriguing brand-new techniques, and also...

Lykos 'remorses' certainly not making known research study transgressions with author

.Psychopharmacology has actually pulled three posts about midstage scientific test information asses...

Analysts dig into Avidity's DMD win, disclosing subtleties in records

.Avidity Biosciences pleased clients with phase 1/2 data in Duchenne muscle dystrophy (DMD) Friday, ...

Actinogen's cortisol blocker fails phase 2 clinical depression study

.Actinogen Medical's cortisol blocker has actually missed the major endpoint of a phase 2 research i...

Bivictrix determines going private only way to take ADC in to facility

.Antibody-drug conjugates (ADCs) have gone to the facility of many a billion-dollar biobuck licensin...

TPG tops up funds to $580M for expenditures all over lifestyle sciences

.Asset manager TPG, which has sustained biotechs including Sionna Therapies and Santa Ana Bio, has a...